High materiality7/10
Teva price target raised to $47 from $42 at Barclays
Why it may matterVerify against the original reporting
bullish upgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises Teva price target to $47 from $42. Posted price: $40.72. Price change since signal: +1.92.
- Barclays raises TEVA target to $47; price $40.72; +1.92 since signal.
Key facts
- 01
Target: $47
- 02
Posted price: $40.72
- 03
Analyst firm: Barclays
- 04
Analyst: Glen Santangelo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.